Drug intelligence / Profile preview

FP1198

Development stage: Preclinical
Modality: Small Molecules
Administration: Topical

Overview

FP1198 is an investigational drug evaluated for the **treatment of moderate to severe cyclic mastalgia (cyclic breast pain)**. It is administered **topically**. Details on its exact chemical class, mechanism of action, molecular structure, or further pharmaceutical properties are not currently publicly available. The main information comes from a clinical trial focused on pain associated with cyclical breast pain.

Beyond the preview

Go deeper on FP1198.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FP1198.

Explore the full profile